Archive | 2021
Can the BMI-Based Dose Regimen be Used to Reduce Injection Activity and to Obtain a Constant Image Quality in Oncological Patients by 18F-FDG Total-Body PET/CT Imaging?
Abstract
\n Purpose PET image quality is influenced by the patient size according to the current guideline. The purpose was to propose an optimized dose regimen to yield a constant image quality independent of patient size to meet the clinical needs.Methods A first patient cohort of 78 consecutives for oncological patients (59.7±13.7 years) who underwent a total-body PET/CT scan were retrospectively enrolled to develop the regimen. The patients were equally distributed in four BMI groups according to WHO criteria. The liver SNR (Signal noise ratio, SNRL) was obtained through manually drawing ROIs and normalized (SNRnorm) by the injected activity and acquisition time. And fits of SNRnorm against different patient-dependent parameters were performed to determine the best correlating parameter and fit method. A qualitative assessment on image quality was performed using a 5-point Likert scale to determine the acceptable threshold of SNRL. And thus, an optimized regimen was proposed and validated by a second patient cohort with prospectively enrolled 38 oncological patients. Results The linear fit showed SNRnorm was the strongest correlation (R2 = 0.69) with the BMI than other patient-dependent parameters. The qualitative assessment revealed a SNRL of 14.0 as a threshold to achieve a sufficient image quality. The optimized dose regimen was determined as a quadratic relation with BMI: Injected activity = 39.2 MBq/(-0.03*BMI+1.49)2. In the validation study, the SNRL no longer decreased with the increase of BMI. There was no significant difference of the image quality, the SNRL, between different BMI groups (p > 0.05). In addition, the injected activity was reduced by 75.6±2.9 %, 72.1±4.0 %, 67.1±4.4 % and 64.8±3.5 % compared to the first cohort for the four BMI groups, respectively.Conclusion The study recommended a quadratic relation between the 18F-FDG injected activity and the patient’s BMI and propose a regimen for total-body PET imaging. In the regimen, the image quality can maintain in a constant level independent of patient size and meet the clinical requirement even with a reduced injected activity.